世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い



世界の再生医療市場の予測と分析 2020-2024年:技術毎、地域毎

Regenerative Medicine Market by Technology and Geography - Forecast and Analysis 2020-2024

IRTNTR41171

 

出版社 出版日電子媒体価格ページ数
TechNavio
テクナビオ
2020年2月 US$ 2,500
シングルユーザライセンス
120p

サマリー

この調査レポートは世界の再生医療市場を分析・予測したテクナビオ(TechNavio)の市場調査報告書です。


Global Regenerative Medicine Market 2020-2024

Technavio has been monitoring the global regenerative medicine market and it is poised to grow by USD  9.55 bn during 2020-2024, progressing at a CAGR of 20% during the forecast period. Our reports on global regenerative medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.  

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases.

In addition, increasing number of clinical trials is anticipated to boost the growth of the global regenerative medicine market as well.

Market Segmentation
 
Technavio---s global regenerative medicine market is segmented as below:  

Technology

  • Cell and tissue-based
  • Gene therapy

Geographic segmentation

  • North America
  • Europe
  • Asia
  • ROW


Key Trends for global regenerative medicine market growth

This study identifies increasing number of clinical trials as the prime reasons driving the global regenerative medicine market growth during the next few years.

Prominent vendors in global regenerative medicine market

We provide a detailed analysis of around 25 vendors operating in the global regenerative medicine market, including some of the vendors such as Allergan Plc,  Amgen Inc.,  Hitachi Chemical Co. Ltd.,  Integra LifeSciences Holdings Corp.,  Medtronic Plc,  MiMedx Group Inc.,  Organogenesis Holdings Inc.,  Smith & Nephew Plc,  Takeda Pharmaceutical Co. Ltd. and  Zimmer Biomet Holdings Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.  

About Technavio

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio---s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.



目次

-    Executive Summary
o    Market Overview
-    Market Landscape
o    Market ecosystem
o    Value chain analysis
-    Market Sizing
o    Market definition
o    Market segment analysis
o    Market size 2019
o    Market outlook: Forecast for 2019 - 2024
-    Five Forces Analysis
o    Five Forces Summary
o    Bargaining power of buyers
o    Bargaining power of suppliers
o    Threat of new entrants
o    Threat of substitutes
o    Threat of rivalry
o    Market condition
-    Market Segmentation by Technology
o    Market segments
o    Comparison by Technology placement
o    Cell and tissue-based - Market size and forecast 2019-2024
o    Gene therapy - Market size and forecast 2019-2024
o    Market opportunity by Technology
-    Customer landscape
o    Overview
-    Geographic Landscape
o    Geographic segmentation
o    Geographic comparison
o    North America - Market size and forecast 2019-2024
o    Europe - Market size and forecast 2019-2024
o    Asia - Market size and forecast 2019-2024
o    ROW - Market size and forecast 2019-2024
o    Key leading countries
o    Market opportunity by geography
-    Drivers, Challenges, and Trends
o    Market drivers
o    Volume driver - Demand led growth
o    Volume driver - Supply led growth
o    Volume driver - External factors
o    Volume driver - Demand shift in adjacent markets
o    Price driver - Inflation
o    Price driver - Shift from lower to higher priced units
o    Market challenges
o    Market trends
-    Vendor Landscape
o    Overview
o    Vendor landscape
o    Landscape disruption
-    Vendor Analysis
o    Vendors covered
o    Market positioning of vendors
o    Allergan Plc
o    Amgen Inc.
o    Hitachi Chemical Co. Ltd.
o    Integra LifeSciences Holdings Corp.
o    Medtronic Plc
o    MiMedx Group Inc.
o    Organogenesis Holdings Inc.
o    Smith & Nephew Plc
o    Takeda Pharmaceutical Co. Ltd.
o    Zimmer Biomet Holdings Inc.
-    Appendix
o    Scope of the report
o    Currency conversion rates for US$
o    Research methodology
o    List of abbreviations
-    Exhibits
-    1.Key Finding 1
-    2.Key Finding 2
-    3.Key Finding 3
-    4.Key Finding 4
-    5.Key Finding 5
-    6.Key Finding 6
-    7.Key Finding 7
-    8.Market in focus
-    9.Parent market
-    10.Market characteristics
-    11.Product / Service portfolio of key vendors included in the market definition
-    12.Market segments
-    13.Global - Market size and forecast 2019 - 2024 ($ million)
-    14.Global market: Year-over-year growth 2019 - 2024 (%)
-    15.Five forces analysis 2019 & 2024
-    16.Bargaining power of buyers
-    17.Bargaining power of suppliers
-    18.Threat of new entrants
-    19.Threat of substitutes
-    20.Threat of rivalry
-    21.Market condition - Five forces 2019
-    22.Technology placement - Market share 2019-2024 (%)
-    23.Comparison by Technology placement
-    24.Cell and tissue-based - Market size and forecast 2019-2024 ($ million)
-    25.Cell and tissue-based - Year-over-year growth 2019-2024 (%)
-    26.Gene therapy - Market size and forecast 2019-2024 ($ million)
-    27.Gene therapy - Year-over-year growth 2019-2024 (%)
-    28. Market opportunity by Technology
-    29.Customer landscape
-    30.Market share by geography 2019-2024 (%)
-    31.Geographic comparison
-    32.North America - Market size and forecast 2019-2024 ($ million)
-    33.North America - Year-over-year growth 2019-2024 (%)
-    34.Europe - Market size and forecast 2019-2024 ($ million)
-    35.Europe - Year-over-year growth 2019-2024 (%)
-    36.Asia - Market size and forecast 2019-2024 ($ million)
-    37.Asia - Year-over-year growth 2019-2024 (%)
-    38.ROW - Market size and forecast 2019-2024 ($ million)
-    39.ROW - Year-over-year growth 2019-2024 (%)
-    40.Key leading countries
-    41.Market opportunity by geography ($ million)
-    42.Impact of drivers
-    43.Impact of challenges
-    44.Landscape disruption
-    45.Industry risks
-    46.Vendors covered
-    47.Market positioning of vendors
-    48.Allergan Plc - Overview (1/3)
-    49.Allergan Plc - Overview (2/3)
-    50.Allergan Plc - Overview (3/3)
-    51.Allergan Plc - Business segments
-    52.Allergan Plc - Key offerings
-    53.Allergan Plc - Key customers
-    54.Allergan Plc - Segment focus
-    55.Amgen Inc. - Overview (1/3)
-    56.Amgen Inc. - Overview (2/3)
-    57.Amgen Inc. - Overview (3/3)
-    58.Amgen Inc. - Business segments
-    59.Amgen Inc. - Key offerings
-    60.Amgen Inc. - Key customers
-    61.Amgen Inc. - Segment focus
-    62.Hitachi Chemical Co. Ltd. - Overview (1/3)
-    63.Hitachi Chemical Co. Ltd. - Overview (2/3)
-    64.Hitachi Chemical Co. Ltd. - Overview (3/3)
-    65.Hitachi Chemical Co. Ltd. - Business segments
-    66.Hitachi Chemical Co. Ltd. - Key offerings
-    67.Hitachi Chemical Co. Ltd. - Key customers
-    68.Hitachi Chemical Co. Ltd. - Segment focus
-    69.Integra LifeSciences Holdings Corp. - Overview (1/3)
-    70.Integra LifeSciences Holdings Corp. - Overview (2/3)
-    71.Integra LifeSciences Holdings Corp. - Overview (3/3)
-    72.Integra LifeSciences Holdings Corp. - Business segments
-    73.Integra LifeSciences Holdings Corp. - Key offerings
-    74.Integra LifeSciences Holdings Corp. - Key customers
-    75.Integra LifeSciences Holdings Corp. - Segment focus
-    76.Medtronic Plc - Overview (1/3)
-    77.Medtronic Plc - Overview (2/3)
-    78.Medtronic Plc - Overview (3/3)
-    79.Medtronic Plc - Business segments
-    80.Medtronic Plc - Key offerings
-    81.Medtronic Plc - Key customers
-    82.Medtronic Plc - Segment focus
-    83.MiMedx Group Inc. - Overview (1/3)
-    84.MiMedx Group Inc. - Overview (2/3)
-    85.MiMedx Group Inc. - Overview (3/3)
-    86.MiMedx Group Inc. - Product and service
-    87.MiMedx Group Inc. - Key offerings
-    88.MiMedx Group Inc. - Key customers
-    89.MiMedx Group Inc. - Segment focus
-    90.Organogenesis Holdings Inc. - Overview (1/3)
-    91.Organogenesis Holdings Inc. - Overview (2/3)
-    92.Organogenesis Holdings Inc. - Overview (3/3)
-    93.Organogenesis Holdings Inc. - Business segments
-    94.Organogenesis Holdings Inc. - Key offerings
-    95.Organogenesis Holdings Inc. - Key customers
-    96.Organogenesis Holdings Inc. - Segment focus
-    97.Smith & Nephew Plc - Overview (1/3)
-    98.Smith & Nephew Plc - Overview (2/3)
-    99.Smith & Nephew Plc - Overview (3/3)
-    100.Smith & Nephew Plc - Business segments
-    101.Smith & Nephew Plc - Key offerings
-    102.Smith & Nephew Plc - Key customers
-    103.Smith & Nephew Plc - Segment focus
-    104.Takeda Pharmaceutical Co. Ltd. - Overview (1/3)
-    105.Takeda Pharmaceutical Co. Ltd. - Overview (2/3)
-    106.Takeda Pharmaceutical Co. Ltd. - Overview (3/3)
-    107.Takeda Pharmaceutical Co. Ltd. - Business segments
-    108.Takeda Pharmaceutical Co. Ltd. - Key offerings
-    109.Takeda Pharmaceutical Co. Ltd. - Key customers
-    110.Takeda Pharmaceutical Co. Ltd. - Segment focus
-    111.Zimmer Biomet Holdings Inc. - Overview (1/3)
-    112.Zimmer Biomet Holdings Inc. - Overview (2/3)
-    113.Zimmer Biomet Holdings Inc. - Overview (3/3)
-    114.Zimmer Biomet Holdings Inc. - Product and service
-    115.Zimmer Biomet Holdings Inc. - Key offerings
-    116.Zimmer Biomet Holdings Inc. - Key customers
-    117.Zimmer Biomet Holdings Inc. - Segment focus
-    118.Currency conversion rates for US$
-    119.Research Methodology
-    120.Validation techniques employed for market sizing
-    121.Information sources
-    122.List of abbreviations

 

COPYRIGHT(C) 2011-2020 DATA RESOURCES, Inc. ALL RIGHTS RESERVED.